Skip to main content

Table 2 Mean spherical equivalent in each group before and after atropine treatment

From: Effects of topical atropine on intraocular pressure and myopia progression: a prospective comparative study

 

Group

 
 

0.125 % Atropine

0.25 Atropine

Control

 

Mean ± SD (D)

Mean ± SD (D)

Mean ± SD (D)

p

Baseline

−1.22 ± 0.55

−1.45 ± 0.69

−1.45 ± 1.00

0.52

3 Months

−1.16 ± 0.63

−1.48 ± 0.72

−1.85 ± 1.17Ø

0.13

6 Months

−1.22 ± 0.70

−1.43 ± 0.80

−2.03 ± 1.28Ø

0.03a

9 Months

−1.19 ± 0.80

−1.42 ± 0.86

−2.20 ± 1.27Ø

<0.01a

1 Year

−1.27 ± 0.85

−1.45 ± 1.00

−2.50 ± 1.31Ø

<0.01a

  1. D Diopter, SD Standard deviation
  2. Analyses of variance among the three groups were performed with the One-way ANOVA and Welch’s test, a indicates significant difference among three groups (p < 0.05)
  3. Analyses of variance from baseline within the group were performed with the paired t test; ØSignificant difference from baseline spherical equivalent (p < 0.05)